1. Home
  2. MRUS vs TGNA Comparison

MRUS vs TGNA Comparison

Compare MRUS & TGNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • TGNA
  • Stock Information
  • Founded
  • MRUS 2003
  • TGNA 1906
  • Country
  • MRUS Netherlands
  • TGNA United States
  • Employees
  • MRUS N/A
  • TGNA N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • TGNA Broadcasting
  • Sector
  • MRUS Health Care
  • TGNA Industrials
  • Exchange
  • MRUS Nasdaq
  • TGNA Nasdaq
  • Market Cap
  • MRUS 4.1B
  • TGNA 2.7B
  • IPO Year
  • MRUS 2016
  • TGNA N/A
  • Fundamental
  • Price
  • MRUS $52.66
  • TGNA $16.93
  • Analyst Decision
  • MRUS Strong Buy
  • TGNA Strong Buy
  • Analyst Count
  • MRUS 12
  • TGNA 4
  • Target Price
  • MRUS $87.92
  • TGNA $20.50
  • AVG Volume (30 Days)
  • MRUS 1.1M
  • TGNA 1.4M
  • Earning Date
  • MRUS 07-31-2025
  • TGNA 08-06-2025
  • Dividend Yield
  • MRUS N/A
  • TGNA 2.95%
  • EPS Growth
  • MRUS N/A
  • TGNA N/A
  • EPS
  • MRUS N/A
  • TGNA 2.83
  • Revenue
  • MRUS $54,732,000.00
  • TGNA $3,067,768,000.00
  • Revenue This Year
  • MRUS $75.57
  • TGNA N/A
  • Revenue Next Year
  • MRUS $31.84
  • TGNA $12.30
  • P/E Ratio
  • MRUS N/A
  • TGNA $6.00
  • Revenue Growth
  • MRUS 42.77
  • TGNA 6.34
  • 52 Week Low
  • MRUS $33.19
  • TGNA $13.37
  • 52 Week High
  • MRUS $62.98
  • TGNA $19.62
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 51.16
  • TGNA 53.59
  • Support Level
  • MRUS $52.53
  • TGNA $16.67
  • Resistance Level
  • MRUS $54.00
  • TGNA $17.17
  • Average True Range (ATR)
  • MRUS 1.69
  • TGNA 0.37
  • MACD
  • MRUS -0.62
  • TGNA 0.04
  • Stochastic Oscillator
  • MRUS 15.89
  • TGNA 65.09

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About TGNA TEGNA Inc

Tegna Inc is a media company with a portfolio of broadcast stations and digital sites. The firm has television stations and radio stations in approximately U.S. markets. The company owns multicast networks of True Crime Network, Twist, and Quest. Each television station also has a robust digital presence across online, mobile, connected television, and social platforms, reaching consumers on all devices and platforms used to consume news content. It generates key revenue from advertising and marketing services, subscriptions, political advertising, and other services.

Share on Social Networks: